Dose responses for topical efficacy and systemic activity, dose equivalence and relative therapeutic index for fluticasone furoate (FF), fluticasone propionate (FP) and budesonide (BUD) in asthmatic subjects

Pneumologie 2020; 74(S 01): 48
DOI: 10.1055/s-0039-3403166

Posterbegehung (PO08) – Sektion Klinische Pneumologie

Klinische Studien bei COPD und Asthma

Georg Thieme Verlag KG Stuttgart · New York

P Daley-Yates

¹Clinical Pharmacology & Experimental Medicine, GlaxoSmithKline, Uxbridge, UK

,

N Brealey

¹Clinical Pharmacology & Experimental Medicine, GlaxoSmithKline, Uxbridge, UK

,

B Kumar

²Biostatistics and Programming, GlaxoSmithKline, Bangalore, India

,

S Thomas

²Biostatistics and Programming, GlaxoSmithKline, Bangalore, India

,

D Austin

¹Clinical Pharmacology & Experimental Medicine, GlaxoSmithKline, Uxbridge, UK

,

S Shabbir

³Medicines Research Centre, GlaxoSmithKline, Stevenage, UK

,

T Harrison

⁴Nottingham Respiratory Research Unit, University of Nottingham, UK

,

D Singh

⁵Medicines Evaluation Unit, University of Manchester, UK

,

N Barnes

⁶Global Medical Franchise, GlaxoSmithKline, Brentford, UK